Zimmer Biomet Reports Third Quarter 2016 Financial Results

Go back to Zimmer Biomet Reports Third Quarter 2016 Financial Results

Needham & Company Upgrades Zimmer Biomet (ZBH) to Strong Buy; Supply Issues Only Temporary

November 1, 2016 7:24 AM EDT

Needham & Company upgraded Zimmer Biomet (NYSE: ZBH) from Buy to Strong Buy with a price target of $148.00 (from $150.00), saying supply issues are only temporary.

Analyst Mike Matson commented, " ZBH missed consensus revenue and met consensus EPS in 3Q16 and management lowered its 2016 guidance.... More

Jefferies Cuts Price Target on Zimmer Biomet Holdings (ZBH) to $129 Following 3Q Miss

November 1, 2016 7:04 AM EDT

Jefferies maintained a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH), and cut the price target to $129.00 (from $150.00), following the company's 3Q earnings report. a $10mn miss was attributed to unforeseen supply chain issues. Revenue guidance was lowered by $58mn, as EPS was cut... More